Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.

Boutros A, McKeown J, Olofsson Bagge R, Ny L, Mattsson J, Spagnolo F, Tanda ET, Gutzmer R, Grover P, Warburton L, Khattak MA, Johnson DB, Maas KP, Burnette H, Sullivan RJ, Effiom D, Lawless AR, Ascierto PA, Vanella V, Gaudy-Marqueste C, Malissen N, Peres T, Javaid A, Idaikkadar P, Lebbé C, Da Meda L, Burke H, Pires da Silva I, van Akkooi ACJ, Carlino MS, Lo SN, Long GV, Menzies AM

Open source

DOI
10.1136/jitc-2026-016060
Published
2026 Oct 7
Container
Journal for immunotherapy of cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2026-016060,
  title = {Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.},
  author = {Boutros A and McKeown J and Olofsson Bagge R and Ny L and Mattsson J and Spagnolo F and Tanda ET and Gutzmer R and Grover P and Warburton L and Khattak MA and Johnson DB and Maas KP and Burnette H and Sullivan RJ and Effiom D and Lawless AR and Ascierto PA and Vanella V and Gaudy-Marqueste C and Malissen N and Peres T and Javaid A and Idaikkadar P and Lebbé C and Da Meda L and Burke H and Pires da Silva I and van Akkooi ACJ and Carlino MS and Lo SN and Long GV and Menzies AM},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2026-016060},
  url = {https://doi.org/10.1136/jitc-2026-016060}
}

RIS

TY  - JOUR
TI  - Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.
AU  - Boutros A
AU  - McKeown J
AU  - Olofsson Bagge R
AU  - Ny L
AU  - Mattsson J
AU  - Spagnolo F
AU  - Tanda ET
AU  - Gutzmer R
AU  - Grover P
AU  - Warburton L
AU  - Khattak MA
AU  - Johnson DB
AU  - Maas KP
AU  - Burnette H
AU  - Sullivan RJ
AU  - Effiom D
AU  - Lawless AR
AU  - Ascierto PA
AU  - Vanella V
AU  - Gaudy-Marqueste C
AU  - Malissen N
AU  - Peres T
AU  - Javaid A
AU  - Idaikkadar P
AU  - Lebbé C
AU  - Da Meda L
AU  - Burke H
AU  - Pires da Silva I
AU  - van Akkooi ACJ
AU  - Carlino MS
AU  - Lo SN
AU  - Long GV
AU  - Menzies AM
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-016060
UR  - https://doi.org/10.1136/jitc-2026-016060
ER  - 

APA

A, B., J, M., R, O. B., L, N., J, M., F, S., ET, T., R, G., P, G., L, W., MA, K., DB, J., KP, M., H, B., RJ, S., D, E., AR, L., PA, A., V, V., C, G., N, M., T, P., A, J., P, I., C, L., L, D. M., H, B., I, P. D. S., ACJ, V. A., MS, C., SN, L., GV, L., & AM, M. (2026). Impact of adjuvant therapy on melanoma-specific survival in elderly patients with high-risk resected melanoma: a multicenter international retrospective study.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2026-016060

Source records